Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis

DSpace Repository

Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis

Author: Lallas, Konstantinos; Chatziioannou, Eftychia; Durak, Derya; Frey, Georg; Serna-Higuita, Lina Maria; Rasch, Marie-Lena; Kyrgidis, Athanassios; Timotheadou, Eleni; Apalla, Zoe; Leiter, Ulrike; Flatz, Lukas; Lallas, Aimilios; Amaral, Teresa
Tübinger Autor(en):
Chatziioannou, Eftychia
Durak, Derya
Frey, Georg
Serna Higuita, Lina María
Rasch, Marie-Lena
Flatz, Lukas
Amaral, Teresa
Leiter-Stöppke, Ulrike
Published in: Frontiers in Immunology (2025), Bd. 16, Article 1524945
Verlagsangabe: Lausanne : Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fimmu.2025.1524945
ISSN: 1664-3224
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)